Pharmacosmos and G1 Therapeutics announced that Pharmacosmos has completed the previously announced tender offer to acquire all outstanding shares of G1 Therapeutics for $7.15 per share net to the holder in cash, without interest and less any applicable withholding taxes, for a total equity value of approximately $405 million.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GTHX:
- Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period
- G1 Therapeutics, Pharmacosmos announce expiration of HSR waiting period
- Largest borrow rate increases among liquid names
- Biotech Alert: Searches spiking for these stocks today
- G1 Therapeutics reports Q2 EPS (10c), consensus (16c)